StockData
Aytu BioPharma, Inc logo

Aytu BioPharma, Inc (AYTU) stock

AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3070% below fair value
$2.66+0.84 (+46.15%)

Close on Nov 17, 2026Market cap $28.91MP/E –Yield –

Aytu BioPharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Aytu BioPharma's price to book ratio was 0.6× on Nov 11, 2026, against 0.9× a year earlier. Over the last 5 years it ranged from 0.1× to 2.1×, with a median of 0.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.6×−0.6
2025Dec 31, 20251.1×+0.8
2024Dec 31, 20240.4×−0.1
2023Dec 29, 20230.5×+0.2
2022Dec 30, 20220.2×−0.1
2021Dec 31, 20210.3×−0.5
2020Dec 31, 20200.8×−6.7
2019Dec 31, 20197.5×+7.4
2018Dec 31, 20180.1×−1.3
2017Dec 29, 20171.5×+0.6
2016Dec 30, 20160.9×−3.2
2015Dec 31, 20154.0×–

More Aytu BioPharma figures

See a number that looks wrong?